EBF vs. BMY
Compare and contrast key facts about Ennis, Inc. (EBF) and Bristol-Myers Squibb Company (BMY).
Performance
EBF vs. BMY - Performance Comparison
Loading graphics...
EBF vs. BMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EBF Ennis, Inc. | 20.60% | -9.96% | 12.59% | 3.64% | 19.38% | 14.78% | -13.46% | 17.54% | -2.77% | 24.65% |
BMY Bristol-Myers Squibb Company | 13.77% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | -12.90% | 7.71% |
Fundamentals
EBF:
$2.45
BMY:
$3.46
EBF:
8.73
BMY:
17.53
EBF:
0.51
BMY:
1.00
EBF:
4.03
BMY:
2.57
EBF:
$92.70M
BMY:
$48.19B
EBF:
$27.36M
BMY:
$30.43B
EBF:
$75.48M
BMY:
$13.82B
Returns By Period
In the year-to-date period, EBF achieves a 20.60% return, which is significantly higher than BMY's 13.77% return. Over the past 10 years, EBF has outperformed BMY with an annualized return of 7.25%, while BMY has yielded a comparatively lower 2.72% annualized return.
EBF
- 1D
- -1.52%
- 1M
- 1.47%
- YTD
- 20.60%
- 6M
- 20.54%
- 1Y
- 12.62%
- 3Y*
- 9.61%
- 5Y*
- 7.39%
- 10Y*
- 7.25%
BMY
- 1D
- 1.54%
- 1M
- -2.76%
- YTD
- 13.77%
- 6M
- 37.94%
- 1Y
- 4.47%
- 3Y*
- 0.11%
- 5Y*
- 3.12%
- 10Y*
- 2.72%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EBF vs. BMY — Risk / Return Rank
EBF
BMY
EBF vs. BMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ennis, Inc. (EBF) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EBF | BMY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.56 | 0.16 | +0.40 |
Sortino ratioReturn per unit of downside risk | 0.94 | 0.43 | +0.51 |
Omega ratioGain probability vs. loss probability | 1.11 | 1.05 | +0.06 |
Calmar ratioReturn relative to maximum drawdown | 0.78 | 0.22 | +0.56 |
Martin ratioReturn relative to average drawdown | 1.60 | 0.35 | +1.25 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| EBF | BMY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.56 | 0.16 | +0.40 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.35 | 0.13 | +0.22 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.28 | 0.11 | +0.17 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.19 | 0.35 | -0.16 |
Correlation
The correlation between EBF and BMY is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
EBF vs. BMY - Dividend Comparison
EBF's dividend yield for the trailing twelve months is around 4.67%, more than BMY's 4.11% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EBF Ennis, Inc. | 4.67% | 5.55% | 16.60% | 4.56% | 4.51% | 4.86% | 5.04% | 4.16% | 4.94% | 3.61% | 11.67% | 3.64% |
BMY Bristol-Myers Squibb Company | 4.11% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
Drawdowns
EBF vs. BMY - Drawdown Comparison
The maximum EBF drawdown since its inception was -73.10%, roughly equal to the maximum BMY drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for EBF and BMY.
Loading graphics...
Drawdown Indicators
| EBF | BMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -73.10% | -72.03% | -1.07% |
Max Drawdown (1Y)Largest decline over 1 year | -15.62% | -25.79% | +10.17% |
Max Drawdown (5Y)Largest decline over 5 years | -22.80% | -47.67% | +24.87% |
Max Drawdown (10Y)Largest decline over 10 years | -35.32% | -47.67% | +12.35% |
Current DrawdownCurrent decline from peak | -1.52% | -13.61% | +12.09% |
Average DrawdownAverage peak-to-trough decline | -20.65% | -22.40% | +1.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.61% | 17.63% | -10.02% |
Volatility
EBF vs. BMY - Volatility Comparison
The current volatility for Ennis, Inc. (EBF) is 5.69%, while Bristol-Myers Squibb Company (BMY) has a volatility of 6.67%. This indicates that EBF experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| EBF | BMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.69% | 6.67% | -0.98% |
Volatility (6M)Calculated over the trailing 6-month period | 13.79% | 19.42% | -5.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.72% | 28.60% | -5.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.02% | 23.66% | -2.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.29% | 25.08% | +1.21% |
Financials
EBF vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Ennis, Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EBF vs. BMY - Profitability Comparison
EBF - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Ennis, Inc. reported a gross profit of -60.33M and revenue of -195.87M. Therefore, the gross margin over that period was 30.8%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Bristol-Myers Squibb Company reported a gross profit of 6.24B and revenue of 12.50B. Therefore, the gross margin over that period was 49.9%.
EBF - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Ennis, Inc. reported an operating income of -25.67M and revenue of -195.87M, resulting in an operating margin of 13.1%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Bristol-Myers Squibb Company reported an operating income of 1.47B and revenue of 12.50B, resulting in an operating margin of 11.8%.
EBF - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Ennis, Inc. reported a net income of 10.83M and revenue of -195.87M, resulting in a net margin of -5.5%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Bristol-Myers Squibb Company reported a net income of 1.09B and revenue of 12.50B, resulting in a net margin of 8.7%.